BDNF and schizophrenia: Consistent with this observation, hippocampal postmortem brain analyses from individuals with schizophrenia revealed elevated expression of brain-derived neurotrophic factor (BDNF) mRNA as well as GluN2B-containing NMDA receptors, and postsynaptic density protein 95 (PSD-95) proteins, particularly in the CA3 subregion, all of which indicate an increase in synaptic strength through, in part, increasing levels of molecules involved in glutamatergic synaptic transmission [39–41].